Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02707601
What this trial is testing

Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment

Who this might be right for
HIV-1 InfectionHCV Infection
Gilead Sciences 150
Early research (Phase 1)Study completedNCT05807971
What this trial is testing

Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects

Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis+1 more
Athos Therapeutics Inc 76
Early research (Phase 1)Looking for participantsNCT06533332
What this trial is testing

Trial of ERX-315 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Breast CancerMetastatic Ovarian Cancer+3 more
EtiraRx Australia Pty Ltd 36
Testing effectiveness (Phase 2)WithdrawnNCT04607655
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Galecto Biotech AB
Early research (Phase 1)Study completedNCT04805307
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

Who this might be right for
Advanced Solid TumorGastric Cancer(Including Gastroesophageal Junction Adenocarcinoma)Pancreatic Cancer
Keymed Biosciences Co.Ltd 176
Testing effectiveness (Phase 2)Study completedNCT00008463
What this trial is testing

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 132
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06452693
What this trial is testing

A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 162
Early research (Phase 1)Ended earlyNCT05561530
What this trial is testing

ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB Subjects

Who this might be right for
Chronic Hepatitis B
Aligos Therapeutics 57
Testing effectiveness (Phase 2)Study completedNCT03776175
What this trial is testing

Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.

Who this might be right for
Non-Alcoholic Fatty Liver Disease (NAFLD)
Pfizer 99
Early research (Phase 1)Study completedNCT02185794
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 101
Early research (Phase 1)Study completedNCT01879462
What this trial is testing

A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 47
Early research (Phase 1)Study completedNCT00970346
What this trial is testing

Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
AlgiPharma AS 26
Early research (Phase 1)Study completedNCT05680454
What this trial is testing

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 160
Early research (Phase 1)Study completedNCT03744182
What this trial is testing

Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD

Who this might be right for
NAFLD
Hanmi Pharmaceutical Company Limited 66
Testing effectiveness (Phase 2)Ended earlyNCT03943446
What this trial is testing

TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery

Who this might be right for
Crohn Disease
Takeda 34
Large-scale testing (Phase 3)Ended earlyNCT01349673
What this trial is testing

The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis

Who this might be right for
ProctitisProctosigmoiditis
Bausch Health Americas, Inc. 114
Early research (Phase 1)Study completedNCT01466569
What this trial is testing

An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor of Epithelial OriginGastric Cancer
AbGenomics B.V Taiwan Branch 13
Testing effectiveness (Phase 2)Study completedNCT00725803
What this trial is testing

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV

Who this might be right for
HCV Infection
Gilead Sciences 33
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT03912532
What this trial is testing

Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
NGM Biopharmaceuticals, Inc 171
Next Page